Department of Emergency, Hubei Maternal and Child Health Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430070 China.
Department of Emergency, the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, 225100 China.
Am J Med Sci. 2024 Aug;368(2):143-152. doi: 10.1016/j.amjms.2024.04.012. Epub 2024 Apr 16.
To evaluate the association of coagulation disorder score with the risk of in-hospital mortality in acute respiratory distress syndrome (ARDS) patients.
In this cohort study, 7,001 adult patients with ARDS were identified from the Medical Information Mart for Intensive Care Database-IV (MIMIC-IV). Univariate and multivariate Logistic stepwise regression models were used to explore the associations of coagulation-associated biomarkers with the risk of in-hospital mortality in patients with ADRS. Restricted cubic spline (RCS) was plotted to explore the association between coagulation disorder score and in-hospital mortality of ARDS patients.
The follow-up time for in-hospital death was 7.15 (4.62, 13.88) days. There were 1,187 patients died and 5,814 people survived in hospital. After adjusting for confounding factors, increased risk of in-hospital mortality in ARDS patients was observed in those with median coagulation disorder score [odds ratio (OR) = 1.22, 95% confidence interval (CI): 1.01-1.47) and high coagulation disorder score (OR = 1.38, 95% CI: 1.06-1.80). The results of RCS indicated that when the coagulation disorder score >2, the trend of in-hospital mortality rose gradually, and OR was >1.
Poor coagulation function was associated with increased risk of in-hospital mortality in ARDS patients. The findings implied that clinicians should regularly detect the levels of coagulation-associated biomarkers for the management of ARDS patients.
评估凝血障碍评分与急性呼吸窘迫综合征(ARDS)患者住院死亡率之间的关联。
在这项队列研究中,从医疗信息互操作存储库-IV(MIMIC-IV)中确定了 7001 名成人 ARDS 患者。使用单变量和多变量逻辑逐步回归模型探讨与 ARDS 患者凝血相关生物标志物与住院死亡率风险之间的关联。绘制限制性立方样条(RCS)以探讨凝血障碍评分与 ARDS 患者住院死亡率之间的关系。
住院死亡的随访时间为 7.15(4.62,13.88)天。有 1187 名患者死亡,5814 人在医院存活。在调整混杂因素后,观察到 ARDS 患者的凝血障碍评分中位数[比值比(OR)=1.22,95%置信区间(CI):1.01-1.47]和高凝血障碍评分(OR=1.38,95%CI:1.06-1.80)增加了住院死亡率的风险。RCS 的结果表明,当凝血障碍评分>2 时,住院死亡率的趋势逐渐升高,OR>1。
凝血功能不良与 ARDS 患者住院死亡率增加相关。研究结果表明,临床医生应定期检测凝血相关生物标志物的水平,以管理 ARDS 患者。